drugset / Trial / NCT06296706

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

NCT06296706 ↗

Phase 3 Recruiting 630 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is a multicenter, randomized, controlled phase Ш clinical study of comparison of Docetaxel for Injection (Albumin-bound) and Taxotere in locally advanced or metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma with previous first-line treatment failure.

Timeline

Start
2024-02-27
Primary completion
2026-06-01
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Docetaxel Small molecule — Intravenous

Indications